Barclays Maintains Overweight on MetLife, Raises Price Target to $111

Benzinga Newsdesk www.benzinga.com Positive 76.6%

Neg 0% Neu 0% Pos 76.6%

Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $97 to $111.